# Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026
Canonical URL: https://biopharmsignal.com/news/CLOV/clover-health-to-report-first-quarter-2026-financial-results-on-may-6-2026
Ticker: CLOV
Company: Clover Health
Source: Clover Health
Published: 2026-04-08 20:05 EST
Original Source URL: https://investors.cloverhealth.com
## Summary

WILMINGTON, Del., April 08, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Wednesday, May 6, 2026.

## Article Body
WILMINGTON, Del., April 08, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Wednesday, May 6, 2026.
## Recent Company News
- 2026-05-06 20:05 EST — [Clover Health Reports First Quarter 2026 Results](https://biopharmsignal.com/news/CLOV/clover-health-reports-first-quarter-2026-results) — Source: Clover Health
- 2026-04-08 20:05 EST — [Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026](https://biopharmsignal.com/news/CLOV/clover-health-to-report-first-quarter-2026-financial-results-on-may-6-2026) — Source: Clover Health
- 2026-04-07 12:30 EST — [Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership](https://biopharmsignal.com/news/CLOV/clover-health-empowers-members-to-take-charge-of-their-health-data-through-healthex-partnership) — Source: Clover Health
- 2026-04-01 12:30 EST — [Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026](https://biopharmsignal.com/news/CLOV/clover-health-announces-departure-of-chief-financial-officer-and-appointment-of-interim-chief-financial-officer-reiterates-most-recently-issued-financial-guidance-for-full-fiscal-year-2026) — Source: Clover Health
- 2026-03-19 12:30 EST — [Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients](https://biopharmsignal.com/news/CLOV/primary-care-physician-use-of-counterpart-assistant-associated-with-18-22-fewer-flu-related-acute-care-events-among-copd-and-chf-patients) — Source: Clover Health
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)